Articles

Martina Bebin, MD, professor of neurology and pediatrics at the University of Alabama at Birmingham Epilepsy Center, detailed the importance of cannabidiol for treatment of TSC.

Tuberous Sclerosis Complex Takes Major Step With Epidiolex Approval

Videos

The professor of neurology and pediatrics at University of Alabama at Birmingham Epilepsy Center discussed the FDA approval of epidiolex for patients with tuberous sclerosis complex. 

Martina Bebin, MD, MPA: Epidiolex and the Novelty of CBD in TSC

The partnership will combine 2 databases with robust historical data in hopes of empowering both research and physician communities and ultimately improving clinical care for patients with tuberous sclerosis complex. 

TS Alliance Partners With Seizure Tracker to Promote Data Sharing

The previously approved therapy is now indicated for treatment in pediatric patients age 2 to 10.

Sabril Label Expanded for Patients 2 to 10 Years Old 

The announcement formally connects Bcureful and the Tuberous Sclerosis Alliance together after working closely together for over the past 8 years. 

Bcureful and Tuberous Sclerosis Alliance Announce Plans to Combine Efforts

The Tuberous Sclerosis Alliance has announced updates to access of everolimus, a drug used to treat several conditions associated with tuberous sclerosis complex. 

Tuberous Sclerosis Alliance

Latest from Tuberous Sclerosis Alliance

New content coming soon, please check back later.